Uptal Patel, MD is an Adjunct Professor interested in population health with a broad range of clinical and research experience. As an adult and pediatric nephrologist with training in health services and epidemiology, his work seeks to improve population health for patients with kidney diseases through improvements in prevention, diagnosis and treatment.
Prior efforts focused on four inter-related areas that are essential to improving kidney health: i) reducing the progression of chronic kidney disease by improving its detection and management, particularly by leveraging technology to facilitate engagement and self-management; ii) elucidating the inter-relationships between kidney disease and cardiovascular disease, which together amplify the risk of death; iii) improving the evidence in nephrology through comparative effectiveness research, including clinical trials, observational studies, and meta-analyses; and iv) promoting more optimal clinical health policy for all patients with kidney disease. These inter-disciplinary projects have been funded by a variety of public and private sources including the Robert Wood Johnson Foundation, Veterans Affairs, National Institutes of Health, Agency for Healthcare Research & Quality, Food and Drug Administration, Centers for Medicare & Medicaid Services, Renal Physicians Association, and the American Society of Nephrology.
Current efforts seek to advance novel therapies for kidney diseases through early clinical development that he leads at AstraZeneca.
Education and Training
- Fellow in Nephrology, Medicine, University of Michigan, Ann Arbor, 2002 - 2003
- Fellow in Pediatric Nephrology, Pediatrics, University of Michigan, Ann Arbor, 2001 - 2002
- Medicine/Pediatric Resident, Medicine/Pediatrics, University of Michigan, Ann Arbor, 1997 - 2001
- M.D., University of California San Francisco, School of Medicine, 1997